Clinical trial
Electronic Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia: An International Prospective Observational Study (eAQUA)
NCT01444456 is registered in ClinicalTrials.gov with Amgen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Electronic Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia: An International Prospective Observational Study (eAQUA)
- Lead sponsor
- Amgen
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- Not reported
- Enrollment
- 1,262 (actual)
- Sites
- 117
Conditions
As the registry lists them; a condition with its own page is linked.
anemia, bladder cancer, breast cancer, cancer, colorectal cancer, endometrial cancer, esophageal cancer, gastric cancer, lung cancer, ovarian cancer, pancreatic cancer, prostate cancer, renal cancer, solid tumors